1 / 10

Towards evidence-based Drug Policies – Experiences from Lao PDR Usefulness of Health Systems Research

Towards evidence-based Drug Policies – Experiences from Lao PDR Usefulness of Health Systems Research. Health Systems Research and National Drug Policy. HSR as a tool in formulating the NDP HSR in strengthening the implementation HSR as a steering mechanism Chanthakhath Paphassarang

rashida
Télécharger la présentation

Towards evidence-based Drug Policies – Experiences from Lao PDR Usefulness of Health Systems Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Towards evidence-based Drug Policies – Experiences from Lao PDR Usefulness of Health Systems Research

  2. Health Systems Research and National Drug Policy • HSR as a tool in formulating the NDP • HSR in strengthening the implementation • HSR as a steering mechanism • Chanthakhath Paphassarang • Lamphone Syhakhang • Sivong Sengaloundeth • Rolf Wahlström, moderator • Food and Drug Department, MoH, Lao PDR • National Institute of Public Health, Lao PDR • IHCAR, Karolinska Institutet, Sweden

  3. Presentations at ICIUMEvidence for Lao NDP implementation • Wed 10.40 Tharatong 1: Assessing implementation of NDP • Wed 15.30 Nanta A: Improving DTC performance • Wed 15.30 Nanta 3: RCT - Management of malaria/diarrhea/ pneumonia in hospitals • Thur 7.45 Tharatong 2: Using MTP for RUD • Thur 15.30 Tharatong 2: Access and RUD in village RDFs • Thur 15.30 Nanta 4: Self-medication with antib. for RTI/STI • Thur 15.30 Lanna: RCT - GPP and regulation • Wed 146: Decision makers and usefulness of research • Wed 149: Accessibility of ED in remote areas • Wed 318: Quality of drugs in private pharmacies • Th-Fr 116: Drug information in private pharmacies

  4. Why has research evidence limited influence on policymaking? • Policymakers have other goals than effectiveness • Research evidence seen as irrelevant • Lack of consensus about research evidence • Other types of competing ‘evidence’ • Social environment not ready for policy change • Poor dissemination of research findings

  5. Research Evidence Health care policy System- adaptation Feedback Implementation Follow up (Muir Gray:2001)

  6. C. L. S. Chanthakhath Lamphone Sivong

  7. Conclusions for useful HSR“Proceed with care” (Black, 2001) • Involve practitioners and policymakers • Identify key problems from practice • Use sound and feasible methods • Reflections along the path - learning circle • Analyse and assess in relation to practice • Make recommendations based on findings • Communicate new knowledge

  8. What can the researcher do? Conclusions in other words (Innvaer, 2002) • Personal and two-way communication with decision makers • Argue for the relevance to the demands of policymakers and the community • Ensure perception of timeliness and high quality • Include effectiveness data • Provide policy recommendation briefs

  9. Success triangle Researcher Practitioner Policymaker

  10. T.T.T. Mind these three T.T.T. Hear their chime Things Take Time (Piet Hein)

More Related